Pharma-Bio Serv (PBSV) Return on Capital Employed (2011 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Return on Capital Employed came in at 3.46% in Q2 2026, up 204.0% YoY from 1.14% in Q2 2025, and up 44.39% on a QoQ basis from 6.22% in Q1 2026.
Pharma-Bio Serv (PBSV) Return on Capital Employed (2011 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has 14 years of Return on Capital Employed data on file, last reported at 3.46% in Q2 2026.
- Quarterly Return on Capital Employed rose 204.0% year-over-year to 3.46% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 3.46% (up 204.0% YoY) and the FY2025 annual result came in at 4.82%, up 312.0% from the prior year.
- Return on Capital Employed grew to 3.46% in Q2 2026, from 6.22% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 7.64% in Q3 2023 to a low of 20.97% in Q3 2022.
- A 5-year average of 4.29% and a median of 5.41% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 2665 bps — and 2023, when it soared 2861 bps.
- Tracing PBSV's Return on Capital Employed over 5 years: stood at 6.39% in 2022, then fell by 3 bps to 6.23% in 2023, then tumbled by 243 bps to 8.93% in 2024, then jumped by 40 bps to 5.37% in 2025, then jumped by 36 bps to 3.46% in 2026.
- The last three Return on Capital Employed figures came in at 3.46% (Q2 2026), 6.22% (Q1 2026), and 5.37% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 13.00% |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 9.85% |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 10.67% |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -9.77% |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 31.58% |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | -8.46% |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 4.91% |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 20.35% |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | -20.94% |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -3.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -3.46% |
| Jan 31, 2026 | -6.22% |
| Oct 31, 2025 | -5.37% |
| Jul 31, 2025 | -5.45% |
| Apr 30, 2025 | -5.50% |
| Jan 31, 2025 | -7.38% |
| Oct 31, 2024 | -8.93% |
| Jul 31, 2024 | -8.05% |
| Apr 30, 2024 | -2.16% |
| Jan 31, 2024 | 2.21% |
| Oct 31, 2023 | 6.23% |
| Jul 31, 2023 | 7.64% |
| Apr 30, 2023 | 6.56% |
| Jan 31, 2023 | 5.79% |
| Oct 31, 2022 | 6.39% |
| Jul 31, 2022 | -20.97% |
| Apr 30, 2022 | -20.08% |
| Jan 31, 2022 | -18.46% |
| Oct 31, 2021 | -16.34% |
| Jul 31, 2021 | 4.23% |